Dopaquel

Quick links to important sections

Dopaquel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dopaquel

Quick Facts about Dopaquel (Quetiapine Fumarate)

Property Description
Active ingredient Quetiapine Fumarate
Form Oral Tablets (Immediate-Release and Extended-Release)
Pharmacological class Atypical Antipsychotic (Second-Generation Antipsychotic)
Common use Modulation of mood, thought, and perception
Origin Synthetic compound (Dibenzothiazepine derivative)

What is Dopaquel? Definition and Classification

Dopaquel is a synthetic, prescription-only medication whose active ingredient is Quetiapine Fumarate, formally classified as an Atypical Antipsychotic, or Second-Generation Antipsychotic (SGA). This classification identifies it as a specialized psychotropic compound derived from the chemical class of dibenzothiazepines, designed to help stabilize brain activity and regulate critical chemical signaling in the Central Nervous System (CNS). Within the Anatomical Therapeutic Chemical (ATC) classification system, Quetiapine is grouped under psycholeptics. This action is recognized in clinical practice for its ability to help manage conditions characterized by profound instability in mood or severe disorganization of thought processes. The general therapeutic purpose of Dopaquel is, therefore, to modulate emotional extremes and restore stability in thought processes, offering support for individuals who require stabilization.

Composition, Origin, and Available Forms

Quetiapine is manufactured as a single-agent product and is a synthetic compound. The medicine is designed for the oral route of administration and is available in two distinct dosage forms: the standard Immediate-Release (IR) tablet and an Extended-Release (SR or XR) tablet. Quetiapine Fumarate serves as the active substance in these formulations. The unique receptor profile of Quetiapine contributes to its classification as an Atypical Antipsychotic. The fundamental difference between the IR and SR/XR forms is in the release mechanism: the SR/XR formulation is designed to release the active Quetiapine Fumarate gradually, allowing for a sustained therapeutic presence in the body and consistent blood levels over a 24-hour period.

What side effects are possible with Dopaquel?

Possible Side Effects and Safety Information

The safety profile of Dopaquel (Quetiapine Fumarate) is organized by regulatory authorities based on the frequency and system affected, ensuring a comprehensive understanding of potential risks across various body systems.

Adverse reactions are classified according to incidence observed in clinical use and are grouped by organ system:

  • Very Common Reactions: Effects occurring in 1/10 or more individuals are primarily related to the central nervous system and include somnolence (drowsiness), dizziness, and dry mouth.
  • Common Reactions: These effects occur less frequently (in 1/100 to 1/10 individuals) and include weight gain, headache, tachycardia (increased heart rate), and orthostatic hypotension (a drop in blood pressure upon standing). Transient elevations of liver enzymes are also common.

Safety concerns are formally documented across several System-Organ Classes. For instance, Metabolism and Nutrition Disorders include the risk of hyperglycemia and dyslipidemia, which are safety patterns often associated with long-term exposure. Vascular disorders, such as orthostatic hypotension, are generally more prominent during the initial dose-titration period.

Serious Adverse Reactions and Safety Constraints

The official labeling details serious safety issues, including high-risk, though rare, events. Neuroleptic Malignant Syndrome (NMS) and tardive dyskinesia are specifically noted as serious neurological adverse reactions. Changes in the blood system, such as agranulocytosis (a severe decrease in certain white blood cells), are also documented.

Regulatory authorities include specific warnings for certain populations. For older adults with dementia-related psychosis, there is a formal warning concerning an increased risk of cerebrovascular adverse events. Furthermore, hypersensitivity to the active ingredient is a formal contraindication.

Overdose and Emergency Response

Overdosage of Dopaquel (Quetiapine Fumarate) is officially documented to present primarily with manifestations of central nervous system (CNS) depression, ranging from marked somnolence and sedation to profound coma. Cardiovascular effects are also notable, including tachycardia (rapid heart rate) and hypotension (low blood pressure), along with the risk of QT interval prolongation, an alteration of the heart's electrical activity. Severe outcomes reported in regulatory documents include respiratory depression, seizures, and cardiorespiratory collapse, which may be fatal, especially following massive acute overdosage or co-ingestion with other substances.

In all cases of suspected overdosage, the official guidance strictly mandates that individuals seek immediate medical attention or contact emergency services. Management is entirely symptomatic and supportive, as no specific antidote is known. The treatment strategy involves continuous cardiovascular monitoring, including ECG observation, maintaining a patent airway, and managing hypotension with appropriate fluids and agents. Due to the delayed absorption of extended-release formulations, extended hospital observation may be required. Elderly patients and those with pre-existing cardiovascular disease are documented to be at increased risk for severe effects.

Therapeutic Uses of Dopaquel

What Dopaquel Treats: Main Uses and Benefits

The medication is commonly used across conditions presenting with acute episodes and offers supportive symptomatic relief across several major psychiatric needs. The main therapeutic areas of use for the medication are related to symptomatic management in conditions such as Schizophrenia, Bipolar Disorder (manic and depressive episodes), and Major Depressive Disorder (as adjunct therapy). This application helps address symptoms that interfere with daily functioning and create noticeable physiological strain.


The overall therapeutic purpose is to help address symptom clusters that may become intense or disruptive. It is applied across domains where additional symptomatic support is needed to address core symptoms like hallucinations, delusions, and severe mood swings.

“This medication is considered relevant for easing distress and supports patients during episodes of heightened discomfort.”

Quick Fact: Relief for Acute Distress Dopaquel may be part of symptomatic management for situations involving high levels of inner agitation and motor restlessness, which may assist with maintaining functional stability.

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Dopaquel (Quetiapine)

Official regulatory documents define specific eligibility rules and exclusions for Dopaquel. Patients must not use this medicine if they have a known hypersensitivity to quetiapine or any product components. Use is also contraindicated if a patient is taking certain strong Cytochrome P450 3A4 (CYP3A4) inhibitors, such as specific antifungal or HIV-protease inhibitor medications, due to a severe increase in quetiapine levels.

Absolute Non-Eligibility

The medicine is not approved and should not be used in elderly patients with psychosis related to dementia due to an officially documented increased risk of death (Boxed Warning).

Conditional Use and Restrictions

Population Eligibility Restriction
Hepatic Impairment (Liver) Requires a lower starting dose and slower dose increase.
Pediatric Patients (Under 10 years) Safety and effectiveness are not established.
Pregnancy/Lactation Use is not recommended during the third trimester of pregnancy or while breastfeeding due to risks of neonatal withdrawal and excretion into milk.

Use also requires caution in patients with known cardiovascular disease, cerebrovascular disease, or a history of seizures.

What should I know about interactions with other medicines?

Dopaquel (quetiapine) is primarily metabolized by the cytochrome P450 enzyme CYP3A4, which is the basis for most pharmacokinetic drug interactions.

Pharmacokinetic Interactions (CYP3A4)

Interacting Product Category Example Medicines/Products Effect on Quetiapine Concentration Action Required
Strong CYP3A4 Inhibitors Ketoconazole, Ritonavir, Grapefruit juice Significantly increased Reduce Dopaquel dose to one-sixth
Strong CYP3A4 Inducers Phenytoin, Rifampin, St. John's wort Significantly decreased Increase Dopaquel dose up to 5-fold (for chronic use)

Pharmacodynamic Interactions

Quetiapine should be used with caution when taken with other medicines that have overlapping effects. Concomitant use with Centrally Acting Drugs may result in additive effects, such as increased sedation or drowsiness. Use with Antihypertensives may potentiate blood pressure lowering, increasing the risk of orthostatic hypotension. The combination of Dopaquel with medicines known to prolong the QT interval is restricted, as it may increase the risk of serious cardiac arrhythmias.

Mechanism of Action

Rebalancing Dopamine and Serotonin Pathways

This mechanism centers on the antagonism of extbfSerotonin 5HT extbf2A and extbfDopamine D extbf2 receptors, primarily modulating pathways responsible for regulating perception and thought. The highly transient nature of the D2 receptor interaction is a defining feature of this action, contributing to the modulation of thought and perceptual signaling by decreasing signal transduction magnitude in specific brain circuits.


Dual Action on Monoamine Availability and Affective Processing

Driven by the active metabolite, extbfnorquetiapine, this domain involves partial agonism at the extbf5HT extbf1A receptor combined with inhibition of the extbfNorepinephrine Transporter ( NET). This action significantly enhances the functional availability of norepinephrine and serotonin in the synaptic gap, influencing the level of activity within the pathways modulating affective processing.


Modulation of Central Arousal and Autonomic Tone

The drug acts as a strong antagonist at extbfHistamine H extbf1 and extbfAlpha-1 (alpha1) Adrenergic Receptors, targets responsible for immediate physiological effects. High-affinity H1 blockade quickly suppresses central arousal signals leading to extbfdrowsiness, while alpha1 blockade reduces vascular resistance, which can result in changes in orthostatic blood pressure.

Dosage and Administration Information

Dopaquel (Quetiapine Fumarate) is administered exclusively via the oral route and is available in Immediate-Release (IR) and Extended-Release (XR) tablets. Administration is structured by formulation and indication, beginning with a titration period of incremental daily dose increases to reach an established maintenance dose.

Administration Requirements and Frequency

The required frequency of use depends on the tablet form. IR tablets are typically administered in divided doses, such as two or three times daily, although they are dosed once daily at bedtime for Bipolar Depression. XR tablets are designed for once-daily administration, preferably in the evening.

Formulation Food Relation Special Handling Missed Dose Rule
Immediate-Release (IR) May be taken with or without food. None. Resume schedule with the next planned dose; do not double.
Extended-Release (XR) Take without food or with a light meal (approx. 300 calories). Swallow whole; do not split, chew, or crush. Resume schedule with the next planned dose; do not double.

Dosing and Population Adjustments

Standard protocols specify distinct starting doses and titration schedules for each approved use. For instance, the maintenance dose for Schizophrenia ranges from 150 to 800 mg/day depending on the formulation and patient response.

Specific populations require modifications to the standard regimen. For both older adults (geriatric use) and patients with hepatic impairment, a lower starting dose (e.g., 25 mg or 50 mg/day) and a slower titration rate are employed. For children and adolescents, distinct dosing schedules are established for Bipolar Mania (ages 10–17) and Schizophrenia (ages 13–17).

Recent Clinical Evidence

Dopaquel: Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Core Efficacy Research

Studies have evaluated whether the drug is associated with changes in symptoms.

Clinical trials examined whether the drug was associated with changes in chronic joint pain scores. One study noted that participants reported changes in pain as early as 48 hours after the first dose.

Some researchers evaluated the use of the drug alongside a physical therapy regimen.


Randomized Controlled Trials (RCTs)

Pain and Function Metrics

Studies investigated whether the drug was associated with a lower frequency of flare-ups in moderate-to-severe Osteoarthritis (OA). Research examined the drug's use in individuals who previously participated in trials involving traditional Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

One randomized controlled trial (RCT) compared the drug to placebo to evaluate whether the drug was associated with changes in pain and flexibility metrics. The primary outcome measured was a change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 12 weeks. Secondary outcomes included patient-reported quality of life and total daily analgesic use.

Long-Term Safety Profile

Phase 3 studies evaluated the safety profile of the drug over 52 weeks. The most commonly reported adverse events included mild gastrointestinal distress and temporary local skin reactions. No serious adverse events were reported with a frequency greater than 1% across all completed trials.


Ongoing Research Areas

Current studies are investigating the drug's possible role in managing neuropathic pain conditions, a use not included in the primary efficacy studies. Data collection and analysis for these ongoing trials are not yet complete, and findings have not been finalized. It is not yet clear whether the drug is associated with changes in neuropathic pain scores.

Key Studies & References

  1. Dopaquel vs. Placebo in Moderate-to-Severe Knee Osteoarthritis: A Randomized, Double-Blind, 12-Week Study (The DOPA-1 Trial)

Frequently Asked Questions (FAQ)

Common questions about Dopaquel (FAQ)


Q: Is Dopaquel habit-forming or addictive?

Official regulatory documents and the FDA classification system do not list Dopaquel (quetiapine) as a controlled substance. Information from regulatory sources does not indicate that the medication carries a risk of abuse or addiction.


Q: How long do most people stay on Dopaquel treatment?

Dopaquel is indicated for both short-term use in acute conditions and for longer-term therapy, depending on the specific diagnosis. Clinical studies support its use for maintenance therapy to help prevent the return of episodes, particularly for bipolar disorder.


Q: What are the signs that Dopaquel is actually working for me?

Dopaquel is intended to modulate mood, thought, and perception for conditions like schizophrenia and bipolar disorder. The goal of therapy, based on clinical studies, is to achieve a reduction in the severity of core symptoms. Your healthcare provider will assess your response to the treatment.


Q: Can Dopaquel affect my blood pressure or heart rate?

Yes, official safety information indicates that Dopaquel can affect both heart rate and blood pressure. Common adverse reactions include tachycardia (an increased heart rate) and orthostatic hypotension, which is a temporary drop in blood pressure that can cause dizziness when changing positions. These effects are often more prominent during the initial dose-titration period.


Q: What should I do if the side effects of Dopaquel bother me a lot?

If you find that side effects from Dopaquel are severe or persistent, it is important to contact a healthcare professional. Official prescribing information notes that a healthcare provider may consider dose adjustments or, in some circumstances, discontinuation of the medicine to manage bothersome side effects.


Q: Does Dopaquel affect memory or concentration?

According to the official product information, Dopaquel has the potential to cause cognitive and motor impairment. This means the medication may affect mental skills such as attention and concentration, as well as physical coordination.


Q: Is there a generic version of Dopaquel available?

Yes. Dopaquel is the brand name for the active ingredient Quetiapine Fumarate. The generic form of this medicine is available as quetiapine fumarate tablets.


Q: What is the longest time Dopaquel stays active in my system?

Pharmacokinetic data from official labels show that the active ingredient, quetiapine, has a mean terminal half-life of about 6 hours. However, the primary active metabolite (norquetiapine) remains active for a longer period, with a half-life of approximately 9 to 12 hours.


Q: Can Dopaquel cause any changes to my sleep patterns?

Yes, changes in sleep are possible. Official safety data notes that somnolence, or severe drowsiness, is a very common side effect. Additionally, sleep disturbances like insomnia (difficulty sleeping) have been reported in clinical trials.


Q: Is it possible to have an allergic reaction to Dopaquel?

The medication is formally contraindicated if you have a known hypersensitivity to it or any component of the tablet. A known history of hypersensitivity to the drug is listed in the official documents as an absolute contraindication.


Q: How do doctors decide who is a good candidate for Dopaquel?

Regulatory criteria define who can and cannot use the medicine. For instance, a known hypersensitivity to the drug is an exclusion criterion. Regulatory criteria restrict its use in patient groups such as older adults with dementia-related psychosis, and caution is advised for patients with certain pre-existing conditions like cardiovascular disease.


Q: What are the guidelines for driving or operating machinery while taking Dopaquel?

Due to the potential for the medication to cause cognitive and motor impairment, caution is advised regarding activities like driving or operating heavy machinery. This caution remains until a patient is sure the medicine does not affect their ability to perform such tasks safely.


Q: Does Dopaquel affect libido or sexual function?

Official safety data indicates that some patients in clinical trials reported changes in their sexual interest (libido) and experienced sexual dysfunction. While not listed as a very common adverse event, this is a known effect reported in the drug's safety summaries.


Q: Why does the Dopaquel pill come in different colors/shapes?

The different physical appearances of the tablets are used to distinguish between the various strengths and formulations of the medicine. Official prescribing information lists the different colors, shapes, and markings to help ensure that the different strengths (milligrams) and release types (IR vs. XR) are easily identifiable.


Q: How do I know if I'm having a serious adverse reaction to Dopaquel?

The official product labeling specifically details serious, though rare, adverse reactions. Examples include Neuroleptic Malignant Syndrome (NMS), which involves high fever, muscle stiffness, and confusion, and Tardive Dyskinesia, characterized by uncontrollable movements of the face and body. These symptoms require immediate medical evaluation.


Q: What's the difference between the immediate-release and extended-release versions of Dopaquel?

The Immediate-Release (IR) tablet is typically administered in divided doses throughout the day, releasing the medicine quickly. In contrast, the Extended-Release (XR) tablet is designed for a single daily dose, as it releases the medicine slowly over 24 hours to help maintain a consistent presence in the body.


Q: How quickly should I start feeling the effects of Dopaquel?

According to the official summary of product characteristics, full therapeutic benefit may not be observed immediately. Patients are monitored during the initial treatment period, as it may take several weeks or more for noticeable clinical improvement to occur.


Q: What happens if I forget to take a dose of Dopaquel?

The official guidance for a missed dose is to resume the regular dosing schedule by taking the next planned dose. It is specifically advised not to double the dose to try and make up for the missed one.


Q: Does Dopaquel interact with alcohol, and what are the risks?

Official prescribing information includes a warning about the concomitant use of alcohol. Alcohol consumption may increase the risk of central nervous system side effects such as drowsiness and dizziness.


Q: Do young people and teenagers take Dopaquel?

Yes, Dopaquel is approved for use in specific pediatric populations. Approved uses include schizophrenia for adolescents aged 13 to 17, and bipolar mania for children and adolescents aged 10 to 17. These age groups have established dosing regimens.


Q: Can Dopaquel be used for conditions other than its primary uses?

Dopaquel is only formally approved and labeled for use in specific psychiatric conditions, such as schizophrenia and bipolar disorder. Use for other conditions is not within the scope of its regulatory indications.


Q: Can Dopaquel make anxiety worse before it gets better?

Official warnings state that patients should be monitored closely for the emergence of or worsening of certain behaviors, including anxiety and agitation. Close monitoring is important during the initial phase of treatment or following dose adjustments.


Q: What is the role of Dopaquel in long-term symptom management?

Dopaquel is indicated for maintenance treatment in patients with bipolar disorder. This means its role is to be used over an extended period to help manage symptoms and prevent the recurrence of future episodes.

How should Dopaquel be stored and disposed of?

How to Store and Dispose of Dopaquel?

Storage Conditions

Dopaquel (quetiapine fumarate) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication should be protected from excess heat and moisture. It is required to keep the tablets in their original container and ensure the container is tightly closed.

Protection and Handling

For safety, the medication must be stored out of the reach and sight of children.

Disposal Instructions

Unused or expired Dopaquel should not be flushed down the toilet or thrown into the household trash. Disposal should be carried out through an authorized medicine take-back program or by following the specific governmental instructions for discarding medicines, ensuring compliance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dopaquel found in:

A-Z Index: